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Purpose: The objectives of this study were 1) to identify the impact of systemic lupus 
erythematosus (SLE) on patients’ lives and their reactions to this, as well as their main concerns 
and expectations regarding their disease and treatments; and 2) to assess the relationship between 
these concerns and the adherence to treatments, medical visits, and diagnostic tests.
Patients and methods: Qualitative study, using a convenient sample of SLE patients 
attending an outpatient rheumatology clinic. Semistructured interviews were conducted and 
audiotaped. The full transcripts were analyzed by two different coders using content analysis 
methodology.
Results: Fifteen participants were included. SLE had a major impact on these patients’ lives. 
Their main concerns were fear of disease worsening and becoming dependent on other people, 
fear of not being able to take care of their children or provide for the family, and the possibility 
of transmitting SLE to their offspring. The main reasons for adherence to therapy were the wish 
to avoid manifestations of SLE and trust in the rheumatologist and routine. Nonadherence was 
more common in the beginning of the treatment because of the difficulty in accepting a chronic 
disease that requires lifelong therapy.
Conclusion: Our data underlined the important interplay between adherence to medication 
and the possibility to gather accurate information and proper support during the treatment 
process. Good communication and efficient patient education strategies, focused on improving 
their knowledge about the disease and its treatments, may be important to improve adherence 
to therapy in SLE.
Keywords: illness perception, adherence, communication, patients’ perspectives, qualitative 
research
Introduction
Systemic lupus erythematosus (SLE) is a complex chronic autoimmune rheumatic 
disease with a marked female predominance. It can affect multiple organ systems and 
is responsible for increased morbidity and mortality.1
There is evidence that adequate treatment can improve clinical outcomes.2 However, 
studies have shown high rates of nonadherence in SLE patients.3 Some studies have 
focused on the reasons for noncompliance with pharmacological therapy.4,5 The 
explanations found in a qualitative study with 31 interviews were “the belief that lupus 
could and should be controlled using alternative methods, the belief that long-term 
use of drugs was not necessary, the fear of drug adverse effects, practical difficulties 
in obtaining medications, and poor communication between patients and physicians”.4 
In Portugal, as opposed to the UK and Jamaica, where Chambers and collaborators 
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conducted their research,4,5 the national healthcare system 
provides SLE patients all their prescribed medications, free 
of charge, regardless of whether they are followed in a public 
hospital or a private practice. Therefore, we presume Portu-
guese patients will differ from those in the UK and Jamaica 
in terms of reasons for nonadherence.
Illness perception has an important influence on treatment 
adherence and disease outcomes.6,7 Some studies explored 
factors influencing SLE patients’ perception of their illness 
and its treatment. A recent quantitative study6 suggested a 
significant relationship between alexithymia and several 
aspects of SLE patients’ perceived health. This relationship 
seemed to be mediated by the development of depressive 
symptoms, which played an important role in “modulating 
patients’ perception of treatment efficacy and emotional 
responses to illness”.6 Other studies supported the association 
of illness perceptions with levels of depression.8
Qualitative approaches can provide richer information 
about patients’ perspectives and their relationships with 
healthcare providers.9 This kind of studies has been widely 
used in musculoskeletal research,10 in some cases including the 
use of computer-assisted qualitative data analysis software.11,12 
However, few studies have addressed the patient’s perspective 
of how SLE affects their lives. We believe that the concerns 
and expectations of SLE patients influence their adherence 
to treatments and also their compliance with medical visits 
and diagnostic tests proposed. Therefore, our objectives were 
1) to identify the impact of SLE in patients’ lives and their 
reactions to this, as well as their main concerns and expecta-
tions regarding their disease and treatments and 2) to assess 
the relation between these concerns and the adherence to 
treatments, medical visits, and diagnostic tests.
Patients and methods
We performed a qualitative content analysis study using a 
convenient sample of SLE patients attending an outpatient 
rheumatology clinic in a secondary care center. Patients who 
had a medical visit or diagnostic tests scheduled for the dates 
stipulated for the interviews to take place, were invited, via 
telephone, to meet the principal investigator (FF) on the 
same day they would be coming to the hospital (to avoid 
extra dislocations). Patients who accepted the invitation were 
explained face-to-face, by the main researcher, the objec-
tives and design of the study. To be included in the study, 
patients had to meet the following criteria: age $18 years old; 
disease duration $1 year; fulfillment of American College 
of Rheumatology (ACR)13 or Systemic Lupus International 
Collaborating Clinics (SLICC)14 SLE classification criteria; 
and willingness to participate and able to give informed signed 
consent. Patients with cognitive impairment were excluded.
Qualitative studies normally address a limited number 
of cases and include small pools of unstructured rich data. 
Sampling units are purposively generated to achieve data 
saturation. Saturation or redundancy is defined as the point 
when no new information is obtained from further data. 
This is a strategy to determine a sample size in qualitative 
research that indicates the adequate amount of cases to be 
considered. For this type of study, there are no fixed amount 
of cases or standard tests to determine the required data to 
reach saturation, and data collection is very often performed 
alongside the data analysis.15
Semistructured face-to-face interviews were conducted 
by FF1 in a quiet room, in the hospital. This researcher was a 
female Specialist Registrar in Rheumatology with a special 
interest in SLE, but with no previous relationship with the 
participants. Interviews, with an approximate duration of 
30–40 minutes, were conducted in Portuguese, the native 
idiom of both the participants and the interviewer, and 
audiotaped in an anonymized manner. The topics approached 
included demographic data, disease duration and evolution, 
treatments, rheumatology medical visits, adherence, mean-
ing of the disease and its implications, main concerns, and 
expectations and communication with the rheumatologist. 
One pilot interview (not included in the analysis) was per-
formed to test and adjust the protocol.
The full transcripts were integrated into a MAXQDA 
(VERBI GmbH, Germany) project file. The data were ana-
lyzed by two different coders (FF1 and FF2) using content 
analysis methodology16,17 to identify the emerging themes and 
to code the data exhaustively. A codebook was discussed and 
implemented (Table 1) in the software. The codebook was 
refined during the data analysis process. The refinement was 
conducted using the Intercoder Agreement function available 
in MAXQDA, variation 3 (ie, measurement of agreement/
alignment of each individual coded segment). The Intercoder 
Agreement function allowed the comparison and contrast of 
single documents coded by the two coders. For this study, 
the agreement of each individual coded segment was thus 
measured for the first five interviews considering a 90% 
agreement percentage. The aim was to decide which cod-
ing variation in each situation was most accurate, in order 
to improve the codebook (ie, to clarify the definition of the 
subcodes) and to inductively generate new entries in the 
codebook to cover absent themes.
The study was conducted in agreement with the Dec-
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sle patients’ concerns and adherence to therapy – a qualitative study
committee (Comissão de ética do Centro Hospitalar do Baixo 
Vouga, EPE; reference: 15FEB’16 12:03 067770).
Results
Sixteen patients were interviewed and 15 were included in 
the analysis, 14 females and one male (the pilot interview was 
not included). The participants were all Caucasians and had 
a median age of 40 (interquartile range [IQR]: 36–45.5) years 
and a median disease duration of 12 (IQR: 7–16) years. Their 
characteristics are shown in Table 2. Five other patients were 
invited to meet the main researcher: four of them argued that 
they did not have time; one accepted the invitation but missed 
the appointment. All the patients who met the investigator 
Table 1 Analysis grid (MAXQDA codebook)
Categories and subcategories
representations about the disease and associated elements
communication with the rheumatologist/other doctors
Personal feelings and/or expectations
coping strategies
concerns shown
Knowledge about the disease
sources of information about the disease
Personal views on the treatments
Adverse events attributed to treatments
Beliefs about treatments
current or past treatments
reasons for adherence
Wish to avoid manifestations of the disease
routine
Trust in the benefits of the treatment
Trust in the rheumatologist/other doctors
Fear of symptom flare-ups
Other reasons for adherence
reasons for nonadherence
neglect
Adverse reaction to the medication
Belief that the disease can be better treated using alternate methods
Belief that the medications available are not effective
negation of the disease
Devaluation of the disease
Other reasons for nonadherence
complementary information
health services – suggestions for improvement
Adherence to medical visits
Adherence to laboratory, imaging, and other testing
reported evolution of the disease
Other complementary information
reported crisis
First symptoms and diagnosis
implications of the disease
Being discriminated against
Appearance/esthetic aspects
Family planning/limitation of family size
Functional impairment
hospital admissions
impairment of professional activities
impairment of recreational activities
limitation in assistance to the family
limitation in domestic activities
Other implications
Pain
requiring assistance for activities of daily life
reactions to the implications of the disease
Acceptation
Anger
creating distractions/to occupy the mind with something else
Fear
guiltiness




Table 2 characteristics of the participants
N 15





































Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II 
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and were explained about the study agreed to participate. 
The data obtained from this first round of 15 interviews 
granted a correct level of theoretical saturation. Therefore, 
it was not necessary to add entries to the initial pool of data 
since the research topics were fully covered and emerging 
themes inserted in the codebook accordingly.
The participants reported different experiences regarding 
their disease. Some of them had relatively mild manifesta-
tions; for others, SLE was a very debilitating disease. For all 
of them, though, Lupus was a constant presence.
impact of sle and reactions to this
This group of patients found several limitations in their lives 
as a consequence of the disease. First of all, they reported 
pain, fatigue, and other symptoms that interfered with daily-
life, domestic, and professional activities, and with their 
social and sexual lives.
Participant 1: My husband had to bathe me because 
I couldn’t; I want to do a good cleaning in my house but 
many times my hands don’t let me do so.
Participant 5: I used to sell fish in the market. I had to 
quit because of … my hands.
Participant 9: The fact that I feel very sleepy, very 
tired […] interferes with life with my husband because 
sometimes libido goes away; I have a very good group 
of friends. […] We used to go out but sometimes I can’t. 
Then if, for instance, we meet at my place or theirs […] 
they laugh, because I fall asleep.
Participant 15: Having a 5-month-old child and not 
being able to breastfeed him. […] I could not hold him. 
I could not bathe him … Anything … Because I was lying 
in bed. It was very hard.
Another implication perceived by the participants was 
the need to avoid exposure to the sun and, therefore, to some 
outdoor leisure activities. These patients lived at the seaside 
and most of them wished they could go to the beach as they 
did before they had the disease.
Participant 4: For instance, imagine meeting up people […] 
it [SLE] limits […] even a simple picnic in a summer day.
Participant 14: Not being able to go to the beach. 
It leaves me very sad.
Esthetic issues associated with SLE were also reported. 
In fact, appearance changes related to rashes, alopecia, and 
visible joint swelling negatively affected these patients’ lives.
Participant 5: I couldn’t look at the mirror and I was upset 
by people staring at me. Because in summer I am very red 
and in winter I get completely blue. And people stop […] 
in the supermarket […] and stare.
Reactions to their disease evolved with time. From the 
analysis of the interviews, we could realize that this was a 
process with several stages. Initially, there was the difficulty 
in coping with the diagnosis of a chronic disease with all 
its implications. Most participants reported some kind of 
psychological effect and some of them needed help from 
psychiatrists or psychologists.
Participant 1: But I had moments when I felt very angry, 
I got to the point of hurting myself […] I did a cut here, I hit 
the window with my head. Hum, angry because by that time 
we were planning to buy a house and all that affected me.
This group of participants did not show resignation; on the 
contrary, they tried to fight the disease and/or to minimize its 
consequences. At some point, they went through a process of 
adaptation of their lives to the new reality and used several 
strategies to cope with the disease, most of which consisted 
of keeping an active life and trying not to think too much 
about the disease and its consequences. In the end, all of them 
accepted this condition with an attitude of normalization of its 
impact. In fact, most said they had a normal life, even though 
it is possible to infer, from the analysis of the interviews, that 
multiple aspects severely conditioned their lives (restrictions 
related to the disease, chronic medication, pain, etc.).
concerns
Participants were asked about their main concerns regard-
ing their disease and treatments. Emergent themes about 
this topic were mainly the fear of disease worsening and, 
consequently, losing autonomy and becoming dependent on 
others. They also feared that they would not be able to take 
care of their children or to provide for the family, and feared 
the possibility of transmitting SLE to their offspring.
Participant 5: [I worry about] ending up in a wheelchair 
and becoming a burden [to my family].
Participant 1: I could only think, what if I become 
paralyzed and cannot take care of the house, and mainly 
my daughter […] who was still a small child.
Participant 3: I wonder whether I’m being an irrespon-
sible person, for having three children, knowing they may 
have my disease.
Although all participants of our study stated that their 
rheumatologists were attentive and always answered 
their questions, some of them still had doubts about the 
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sle patients’ concerns and adherence to therapy – a qualitative study
created anxiety and other negative feelings. These patients 
admitted that they did not usually share their concerns dur-
ing medical visits, either because they forgot about it or 
because they did not feel it was opportune, as participant 
3 said, “That moment is not always provided, you know? 
Because appointments are one after the other and […] you 
[the doctors] give us enough information but do not stay 
there … talking, right?”
Adherence
The wish to avoid manifestations of SLE was the main reason 
for adherence to therapy. In fact, several patients realized that 
they felt worse if they stopped the medication. For instance, 
participant 5 said, “I have to take them [the medicines] in 
the morning otherwise I’m not able to walk.” Therefore, 
medication appears here as a negative reinforcer, since 
patients adhere mostly to avoid pain and other symptoms. 
Most members of the group were able to express a very good 
level of understanding regarding the therapy, namely, the 
side effects related to some of the medicines.
Another important emerged reason for adherence was 
the trust in the rheumatologist. This became particularly 
clear with participant 10’s interview: “I think it’s more 
important […] to trust in the person [the doctor] that is 
seeing us […] in that case they can prescribe 50 tablets and 
we take them.”
Most patients mentioned that they integrated medication 
in their daily routine, as participant 10 said, “It’s like having 
my yogurt in the morning. It doesn’t bother me, because it 
is a habit.”
These patients felt more confident/reassured knowing 
that they had periodic clinical and laboratory evaluation. 
This was the main reason for them to attend the visits and 
to accept laboratory and other proposed tests.
Participant 9: Therefore, as I do them [the laboratory tests] 
every 4 months, I think […] that reassures me […] a lot.
Nonadherence was not common in this sample. It was 
reported in the beginning of the treatment because of the dif-
ficulty in accepting a chronic disease that requires lifelong 
therapy. Other reasons for nonadherence included oblivion, 
neglect, and adverse effects of the medication.
Participant 4: But in the beginning of course it was hard to 
realize that from that day on I had to take medicines and it’s 
still hard when I’m told: You have to take also this, for all 
your life. It is more medication. [...] The day gets sad.
Participant 9: I used to stop medication from May or 
June on. It was to get slimmer to go to the beach.
Discussion
The impact of SLE in these patients’ lives was mainly char-
acterized by pain, fatigue, and other symptoms that interfered 
with daily-life, domestic, and professional activities, and 
with their social and sexual lives; having to avoid outdoor 
leisure activities; and esthetic issues. These patients went 
through a process of acceptation and adaptation of their lives 
because of the disease. Their main concerns included fear 
of disease worsening and becoming dependent, fear of not 
being able to take care of their children or to provide for 
the family, and the possibility of transmitting SLE to their 
offspring. The main reasons for adherence to therapy were 
the wish to avoid manifestations of SLE and trust in the 
rheumatologist and routine. These patients felt reassured 
knowing that they had periodic clinical and laboratory 
evaluation. Nonadherence was more common in the begin-
ning of the treatment because of the difficulty in accepting 
a chronic disease that requires lifelong therapy. The other 
reasons reported were oblivion, neglect, and adverse effects 
of the medication.
Regarding the impact of lupus in patients’ lives, other 
studies have shown similar results.18,19 Household responsi-
bilities, parenting roles, recreational activities, work perfor-
mance, and scholastic achievement have been reported to be 
affected by the signs and symptoms of SLE.18
A recent study investigated the interactions between 
body image, self-image, medication use, and adherence 
to medication in SLE patients. As in our study, patients 
revealed worries about appearance and weight, which they 
often related with the use of steroids, and also described 
“creative non-compliance”. In that study, participants “felt 
their care providers did not give enough consideration to 
their concerns” about the effects of lupus and its treatment 
on the appearance.20 In contrast, although participants in 
our study appeared to be happy with the relationship they 
had with their rheumatologists, many of them tended not to 
share their concerns.
Another study, which assessed patients with one or 
more chronic diseases, suggested that there is a significant 
relationship between knowledge about medications and the 
tendency to adhere to long-term treatments.21 The same was 
suggested by a study in patients with rheumatoid arthritis: 
patients who reported lower adherence were more dissatisfied 
with the information they had received about their disease-
modifying antirheumatic drugs.22 Rao et al found that the 
most common unfulfilled expectation among patients with 
rheumatic diseases during their visits to rheumatologists 
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infer that lack of information strongly relates to feelings of 
uncertainty and fear.
In summary, good communication between physician and 
patient appears to be essential to improve adherence. It may 
require proper adjustment to patients’ cultural background 
as they describe disease and its effects in different ways. 
As shown in previous studies, it is important to involve the 
patients in decision-making and to help them feel comfortable 
and confident in sharing their questions and concerns.21 This 
will also enable a trustful relationship, which is, according to 
our findings, an important reason for adherence.
Our group of patients tended to adhere well and one of the 
main reasons for this seemed to be the direct link that they 
found between taking the medication and controlling the 
symptoms related to the disease. Therefore, compliance with 
treatments is rewarded with the possibility of living a normal 
life (although it is possible to understand that the very concept 
of normality for Lupus patients comprises a considerable list 
of adaptation strategies). However, since participants were 
recruited among patients who went to the hospital to have 
a medical visit or a laboratory test, it was possible that only 
compliant patients were invited and agreed to participate. 
If this was the case, our sample might not allow enough 
variability for a thorough assessment of motives influencing 
SLE patients’ adherence to treatment. On the other hand, it 
may have happened that some patients did not disclose non-
adherence, as they would have felt uncomfortable admitting 
it in a face-to-face interview. The absence of an anonymous 
quantitative questionnaire to assess treatment adherence 
was, therefore, a limitation of our study, as adherence was 
only assessed through the interviews. It is important to note 
that in Portugal, patients with SLE do not have to pay for 
their prescribed medications; therefore, in contrast to other 
populations, the cost was not the reason for poor adherence 
to pharmacological treatments.
Our study had a limited group of participants, which is 
common in qualitative research and is not seen as a problem, 
since theoretical saturation was achieved. In addition, par-
ticipants differed in terms of disease duration, severity of 
manifestations, and social status. This inhomogeneity is 
usually a characteristic of samples in qualitative studies, 
as it may provide richer information. In fact, these kinds of 
studies are not usually expected to produce generalizable 
results as would be the case with quantitative research.20,24 
Instead, they give us important information that allows us 
to understand this group of patients better and to generate 
concepts that can be transferable and used in clinical practice 
or in future studies. Nevertheless, in light of the Proximal 
Similarity Model, it could be licit to generalize the results of 
our study if there are strong “similarities between the time, 
place, people and other social contexts”.24 An expansion of 
this study, to include a broader population with respect to 
adherence levels, would be important to understand better 
the reasons for nonadherence and to allow for the generaliz-
ability of the results.
Conclusion
Our research data underlined the important interplay between 
adherence to medication and the possibility to gather accurate 
information and proper support during the treatment process. 
The latter is particularly relevant considering the reported 
psychological effects of a disabling chronic disease requir-
ing lifelong therapy. Good communication between physi-
cian and patient may enable trust and, therefore, improve 
adherence. In addition, efficient patient education strategies, 
focused on improving their knowledge about the disease 
and its treatments, may be important to improve adherence 
to therapy in SLE.
Acknowledgment
The abstract of this paper was presented at the 10th Euro-
pean Lupus Meeting, as an oral communication, with 
interim findings. The abstract was published in “Meeting 
Abstracts” in Clinical and Experimental Rheumatology 34 
(4 Suppl 99):S47.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Chambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality 
in a group of British patients with systemic lupus erythematosus followed 
up for over 10 years. Rheumatology (Oxford). 2009;48(6):673–675.
2. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. 
Clinical efficacy and side effects of antimalarials in systemic lupus 
erythematosus: a systematic review. Ann Rheum Dis. 2010;69(1): 
20–28.
3. Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, et al. Adherence 
to treatment in systemic lupus erythematosus patients. Best Pract Res 
Clin Rheumatol. 2013;27(3):329–340.
4. Chambers SA, Raine R, Rahman A, Isenberg D. Why do patients with 
systemic lupus erythematosus take or fail to take their prescribed medi-
cations? A qualitative study in a UK cohort. Rheumatology (Oxford). 
2009;48(3):266–271.
5. Chambers S, Raine R, Rahman A, Hagley K, De Ceulaer K, Isenberg D. 
Factors influencing adherence to medications in a group of patients with 
systemic lupus erythematosus in Jamaica. Lupus. 2008;17(8):761–769.
6. Barbasio C, Vagelli R, Marengo D, et al. Illness perception in systemic 
lupus erythematosus patients: the roles of alexithymia and depression. 
Compr Psychiatry. 2015;63:88–95.
7. Kotsis K, Voulgari PV, Tsifetaki N, Drosos AA, Carvalho AF, Hyphantis T. 
Illness perceptions and psychological distress associated with physical 
health-related quality of life in primary Sjogren’s syndrome compared 

































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Patient Preference and Adherence
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/patient-preference-and-adherence-journal
Patient Preference and Adherence is an international, peer-reviewed, 
open access journal that focuses on the growing importance of patient 
 preference and adherence throughout the therapeutic continuum. Patient 
satisfaction, acceptability, quality of life, compliance, persistence and their 
role in  developing new therapeutic modalities and compounds to optimize 
clinical  outcomes for existing disease states are major areas of interest for 
the  journal. This journal has been accepted for indexing on PubMed Central. 
The  manuscript management system is completely online and includes a very 
quick and fair peer-review system, which is all easy to use. Visit http://www.
dovepress.com/testimonials.php to read real quotes from published authors.





sle patients’ concerns and adherence to therapy – a qualitative study
 8. Philip EJ, Lindner H, Lederman L. Relationship of illness perceptions 
with depression among individuals diagnosed with lupus. Depress 
Anxiety. 2009;26(6):575–582.
 9. Paskins Z, Hassell AB. Qualitative research in RA. Rheumatology. 
2012;51(1):3–4.
 10. Ong BN, Richardson JC. The contribution of qualitative approaches 
to musculoskeletal research. Rheumatology (Oxford). 2006;45(4): 
369–370.
 11. Hayden C, Neame R, Tarrant C. Patients’ adherence-related beliefs 
about methotrexate: a qualitative study of the role of written patient 
information. BMJ Open. 2015;5(5):e006918.
 12. Moverley AR, Vinall-Collier KA, Helliwell PS. It’s not just the joints, 
it’s the whole thing: qualitative analysis of patients’ experience of flare 
in psoriatic arthritis. Rheumatology (Oxford). 2015;54(8):1448–1453.
 13. Hochberg MC. Updating the American College of Rheumatology 
revised criteria for the classification of systemic lupus erythematosus. 
Arthritis Rheum. 1997;40(9):1725.
 14. Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of 
the Systemic Lupus International Collaborating Clinics classification 
criteria for systemic lupus erythematosus. Arthritis Rheum. 2012; 
64(8):2677–2686.
 15. Silverman D, Marvasti A. Doing Qualitative Research: A Comprehensive 
Guide. SAGE Publications; 2008.
 16. Krippendorff K. Content Analysis: An Introduction to Its Methodology. 
3rd ed. California: SAGE Publications; 2013.
 17. Neuendorf K. The Content Analysis Guidebook. California: SAGE 
Publications; 2002.
 18. Robinson D Jr, Aguilar D, Schoenwetter M, et al. Impact of systemic 
lupus erythematosus on health, family, and work: the patient perspec-
tive. Arthritis Care Res (Hoboken). 2010;62(2):266–273.
 19. McElhone K, Abbott J, Shelmerdine J, et al. Development and valida-
tion of a disease-specific health-related quality of life measure, the 
LupusQol, for adults with systemic lupus erythematosus. Arthritis 
Rheum. 2007;57(6):972–979.
 20. Hale ED, Radvanski DC, Hassett AL. The man-in-the-moon face: 
a qualitative study of body image, self-image and medication use in 
systemic lupus erythematosus. Rheumatology (Oxford). 2015;54(7): 
1220–1225.
 21. Awwad O, Akour A, Al-Muhaissen S, Morisky D. The influence of 
patients’ knowledge on adherence to their chronic medications: a cross-
sectional study in Jordan. Int J Clin Pharm. 2015;37(3):504–510.
 22. Kumar K, Raza K, Nightingale P, et al. Determinants of adherence to 
disease modifying anti-rheumatic drugs in White British and South 
Asian patients with rheumatoid arthritis: a cross sectional study. BMC 
Musculoskelet Disord. 2015;16:396.
 23. Rao JK, Weinberger M, Anderson LA, Kroenke K. Predicting reports 
of unmet expectations among rheumatology patients. Arthritis Rheum. 
2004;51(2):215–221.
 24. Leung L. Validity, reliability, and generalizability in qualitative 
































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
